AccScience Publishing / EJMO / Online First / DOI: 10.36922/EJMO026190207
Cite this article
2
Download
40
Views
Related Info Links
Journal Browser
Volume | Year
Issue
Search
News and Announcements
View All
ORIGINAL RESEARCH ARTICLE

Network pharmacology and in silico validation of sesamin targeting AR and MAPK1 in COVID-19 and malaria

Mst. Tania Khatun1† Md. Arju Hossain2† Md. Imran Hasan3 Md. Shohidul Islam3 Md. Ataur Rahman4 Abdel Halim Harrath5 Md. Habibur Rahman3,6* Md Azizul Haque7*
Show Less
1 Department of Biotechnology and Genetic Engineering, Faculty of Biological Sciences, Islamic University, Kushtia, Khulna , Bangladesh
2 Department of Biochemistry and Biotechnology, School of Bio-Medical Science, Khwaja Yunus Ali University, Enayetpur, Rajshahi , Bangladesh
3 Department of Computer Science and Engineering, Faculty of Engineering and Technology, Islamic University, Kushtia, Khulna , Bangladesh
4 Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, Michigan , United States of America
5 Department of Zoology, College of Science, King Saud University, Riyadh , Saudi Arabia
6 Center for Advanced Bioinformatics and Artificial Intelligence Research Lab, Islamic University, Kushtia, Khulna , Bangladesh
7 Department of Biotechnology, College of Life and Applied Science, Yeungnam University, Gyeongsan, Gyeongsangbuk-do , Republic of Korea
†These authors contributed equally to this work.
Received: 8 May 2026 | Revised: 15 July 2026 | Accepted: 7 August 2026 | Published online: 14 September 2026
© 2026 by the Author(s). This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution -Noncommercial 4.0 International License (CC-by the license) ( https://creativecommons.org/licenses/by-nc/4.0/ )
Abstract

Introduction: COVID-19 and malaria may coexist in endemic regions, creating diagnostic and therapeutic challenges, while evidence-based strategies addressing their co-occurrence remain limited.

Objective: This study evaluates sesamin, a natural compound with reported antiviral, antioxidant, anti-inflammatory, and immunomodulatory activities, as a potential multitarget candidate for COVID-19 and malaria.

Methods: Network pharmacology and transcriptomic analyses were used to identify shared targets and pathways among sesamin, COVID-19, and malaria. Molecular docking; absorption, distribution, metabolism, excretion, and toxicity (ADMET) profiling; 200-ns molecular dynamics simulations; and molecular mechanics/generalized Born surface area (MM-GBSA) binding free-energy calculations were performed to assess target interactions, dynamic stability, binding energetics, and predicted pharmacokinetic and toxicity properties.

Results: Seventy common differentially expressed genes were identified. Protein–protein interaction analysis highlighted AR, MAPK1, caspase-3, β-catenin, IL-6, HSP90α, and EGFR as key targets. Enrichment analysis linked the genes of these proteins mainly to apoptosis regulation and to FOXO and PI3K–AKT signaling. Sesamin showed favorable docking with MAPK1, AR, EGFR, CASP3, and β-catenin, with docking scores ranging from −10.0 to −8.6 kcal/mol, more favorable than those of the reference ligands. ADMET analysis indicated a potential Ames toxicity signal but no predicted hepatotoxicity or skin sensitization. During the simulations, sesamin remained stable with AR and MAPK1; the AR-bound system showed greater positional stability and lower solvent exposure, whereas the MAPK1-bound system maintained more hydrogen bonds. MM-GBSA analysis showed favorable binding of sesamin to AR (−55.77 kcal/mol) and MAPK1 (−122.17 kcal/mol).

Conclusion: Sesamin may modulate shared immune and inflammatory pathways relevant to COVID-19 and malaria. Its stable interactions with AR and MAPK1 support further investigation, although experimental and clinical validation is required.

Keywords
Sesamin
Malaria
COVID-19
Androgen receptor
Mitogen-activated protein kinase 1
Molecular dynamics simulations
Phosphoinositide 3-kinase/Protein kinase B
Apoptosis
Funding
The authors extend their appreciation to Ongoing Research Funding project number ORF-2026-17, King Saud University, Riyadh, Saudi Arabia.
Conflict of interest
The authors declare no conflicts of interest.
References
  1. Vilella A, Trilla A. The COVID-19 pandemic—an epidemiological perspective. Curr Allergy Asthma Rep. 2021;21(4):29. doi: 10.1007/s11882-021-01007-w
  2. Sohel M, Hossain M, Hasan M, et al. Management of mental health during COVID 19 pandemic: possible strategies. J Adv Biotechnol Exp Ther. 2021;4(3):276-289. doi: 10.5455/jabet.2021.d128
  3. Dyer O. Covid-19: Omicron is causing more infections but fewer hospital admissions than delta, South African data show. BMJ. 2021;375:n3104. doi: 10.1136/bmj.n3104
  4. Guo C, Yu Y, Liu J, et al. Antigenic and virological characteristics of SARS-CoV-2 variants BA.3.2, XFG, and NB.1.8.1. Lancet Infect Dis. 2025;25(7):e374-e377. doi: 10.1016/S1473-3099(25)00308-1
  5. Prasad K, Khatoon F, Rashid S, et al. Targeting hub genes and pathways of innate immune response in COVID-19: a network biology perspective. Int J Biol Macromol. 2020;163:1-8. doi: 10.1016/j.ijbiomac.2020.06.228
  6. Hussain MW, Mirza T, Hassan MM. Impact of COVID-19 pandemic on the human behavior. Int J Educ Manag Eng. 2020;10(6):35-61. doi: 10.5815/ijeme.2020.05.05
  7. Hu B, Guo H, Zhou P, Shi Z-L. Characteristics of SARS-CoV-2 and COVID19. Nat Rev Microbiol. 2021;19(3):141-154. doi: 10.1038/s41579-020-00459-7
  8. Fikadu M, Ashenafi E. Malaria: an overview. Infect Drug Resist. 2023;16(2023):3339-3347. doi: 10.2147/IDR.S405668
  9. World Health Organization. World Malaria Report 2025. Geneva, Switzerland: World Health Organization; 2025. Accessed July 7, 2026. https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2025
  10. Turner L, Lavstsen T, Berger SS, et al. Severe malaria is associated with parasite binding to endothelial protein C receptor. Nature. 2013;498(7455):502-505. doi: 10.1038/nature12216
  11. Storm J, Jespersen JS, Seydel KB, et al. Cerebral malaria is associated with differential cytoadherence to brain endothelial cells. EMBO Mol Med. 2019;11(2):e201809164. doi: 10.15252/emmm.201809164
  12. Nguyen ST, Du D, Wychrij D, et al. Histidine-rich protein II nanoparticle delivery of heme iron load drives endothelial inflammation in cerebral malaria. Proc Natl Acad Sci USA. 2023;120(26):e2306318120. doi: 10.1073/pnas.2306318120
  13. Konozy EH, Osman ME, Ghartey-Kwansah G, Abushama HM. The striking mimics between COVID-19 and malaria: A review. Front Immunol. 2022;13:957913. doi: 10.3389/fimmu.2022.957913
  14. Mohamed AH, Eltyeb E, Said B, et al. COVID-19 and malaria co-infection: a systematic review of clinical outcomes in endemic areas. PeerJ. 2024;12:e17160. doi: 10.7717/peerj.17160
  15. Kishore R, Dhakad S, Arif N, et al. COVID19: possible cause of induction of relapse of Plasmodium vivax infection. Indian J Pediatr. 2020;87(9):751-752. doi: 10.1007/s12098-020-03441-6
  16. Sardar S, Sharma R, Alyamani TYM, Aboukamar M. COVID-19 and Plasmodium vivax malaria co-infection. IDCases. 2020;21:e00879. doi: 10.1016/j.idcr.2020.e00879
  17. Mahajan NN, Gajbhiye RK, Bahirat S, et al. Co-infection of malaria and early clearance of SARS CoV 2 in healthcare workers. J Med Virol. 2021;93(4):2431-2438. doi: 10.1002/jmv.26760
  18. Rayella C, Devanandan P, Rasuri K, Yerravelly SS, Andem S, Puvvada R. Clinical characteristics of malaria in COVID-19: A systematic review of case reports. Trop Parasitol. 2023;13(1):22-27. doi: 10.4103/tp.tp_26_22
  19. Onosakponome EO, Wogu MN. The role of sex in malaria–COVID19 coinfection and some associated factors in Rivers State, Nigeria. J Parasitol Res. 2020;2020:8829848. doi: 10.1155/2020/8829848
  20. Achan J, Serwanga A, Wanzira H, et al. Current malaria infection, previous malaria exposure, and clinical profiles and outcomes of COVID-19 in a setting of high malaria transmission: an exploratory cohort study in Uganda. Lancet Microbe. 2022;3(1):e62-e71. doi: 10.1016/S2666-5247(21)00240-8
  21. Mahrosh HS, Mustafa G. An in-silico approach to target RNA-dependent RNA polymerase of COVID-19 with naturally occurring phytochemicals. Environ Dev Sustain. 2021;23(11):16674-16687. doi: 10.1007/s10668-021-01373-5
  22. Sohel M, Islam MN, Hossain MA, et al. Pharmacological properties to pharmacological insight of sesamin in breast cancer treatment: a literature-based review study. Int J Breast Cancer. 2022;2022:2599689. doi: 10.1155/2022/2599689
  23. Chen S, Zhang C-L, Shen H-Q, et al. Sesamin protects against DSS-induced colitis in mice by inhibiting NF-κB and MAPK signaling pathways. Food Funct. 2021;12(4):1688-1694. doi: 10.1039/d0fo00950d
  24. Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods. 2008;5(7):621-628. doi: 10.1038/nmeth.1226
  25. Davis AP, Grondin CJ, Johnson RJ, et al. Comparative toxicogenomics database (CTD): update 2021. Nucleic Acids Res. 2021;49(D1):D1138-D1143. doi: 10.1093/nar/gkaa891
  26. Wang X, Shen Y, Wang S, et al. PharmMapper 2017 update: a web server for potential drug target identification with a comprehensive target pharmacophore database. Nucleic Acids Res. 2017;45(W1):W356-W360. doi: 10.1093/nar/gkx374
  27. Daina A, Michielin O, Zoete V. SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res. 2019;47(W1):W357-W364. doi: 10.1093/nar/gkz382
  28. Szklarczyk D, Santos A, Von Mering C, Jensen LJ, Bork P, Kuhn M. STITCH 5: augmenting protein–chemical interaction networks with tissue and affinity data. Nucleic Acids Res. 2016;44(D1):D380-D384. doi: 10.1093/nar/gkv1277
  29. Gill SE, Dos Santos CC, O'Gorman DB, et al. Transcriptional profiling of leukocytes in critically ill COVID19 patients: implications for interferon response and coagulation. Intensive Care Med Exp. 2020;8(1):75. doi: 10.1186/s40635-020-00361-9
  30. Arunachalam PS, Wimmers F, Mok CKP, et al. Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans. Science. 2020;369(6508):1210-1220. doi: 10.1126/science.abc6261
  31. Tran TM, Jones MB, Ongoiba A, et al. Transcriptomic evidence for modulation of host inflammatory responses during febrile Plasmodium falciparum malaria. Sci Rep. 2016;6(1):31291. doi: 10.1038/srep31291
  32. Zaidi I, Diallo H, Conteh S, et al. γδ T cells are required for the induction of sterile immunity during irradiated sporozoite vaccinations. J Immunol. 2017;199(11):3781-3788. doi: 10.4049/jimmunol.1700314
  33. Consortium GO. The Gene Ontology resource: 20 years and still GOing strong. Nucleic Acids Res. 2019;47(D1):D330-D338. doi: 10.1093/nar/gky1055
  34. Kanehisa M. Enzyme annotation and metabolic reconstruction using KEGG. In: Methods in Molecular Biology. Vol 1611. New York, NY: Humana Press; 2017:135-145. doi: 10.1007/978-1-4939-7015-5_11
  35. Szklarczyk D, Gable AL, Nastou KC, et al. The STRING database in 2021: Customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Res. 2021;49(D1):D605-D612. doi: 10.1093/nar/gkaa1074
  36. Reimand J, Isserlin R, Voisin V, et al. Pathway enrichment analysis and visualization of omics data using g:Profiler, GSEA, Cytoscape and EnrichmentMap. Nat Protoc. 2019;14(2):482-517. doi: 10.1038/s41596-018-0103-9
  37. Wang J, Zhong J, Chen G, Li M, Wu FX, Pan Y. ClusterViz: a cytoscape APP for cluster analysis of biological network. IEEE/ACM Trans Comput Biol Bioinforma. 2014;12(4):815-822. doi: 10.1109/TCBB.2014.2361348
  38. Chin C-H, Chen S-H, Wu H-H, Ho CW, Ko MT, Lin CY. cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014;8(Suppl 4):S11. doi: 10.1186/1752-0509-8-S4-S11
  39. Bardou P, Mariette J, Escudié F, Djemiel C, Klopp C. Jvenn: An interactive Venn diagram viewer. BMC Bioinformatics. 2014;15(1):293. doi: 10.1186/1471-2105-15-293
  40. Rydenfelt M, Klinger B, Klünemann M, Blüthgen N. SPEED2: inferring upstream pathway activity from differential gene expression. Nucleic Acids Res. 2020;48(W1):W307-W312. doi: 10.1093/nar/gkaa236
  41. Azzam KA. SwissADME and pkCSM Webservers Predictors: an integrated Online Platform for Accurate and Comprehensive Predictions for In Silico ADME/T Properties of Artemisinin and its Derivatives. Complex Use Miner Resour. 2022;325(2):14-21. doi: 10.31643/2023/6445.13
  42. Banerjee P, Kemmler E, Dunkel M, Preissner R. ProTox 3.0: a webserver for the prediction of toxicity of chemicals. Nucleic Acids Res. 2024;52(W1):W513-W520. doi: 10.1093/nar/gkae303
  43. Saikia S, Bordoloi M. Molecular docking: challenges, advances and its use in drug discovery perspective. Curr Drug Targets. 2019;20(5):501-521. doi: 10.2174/1389450119666181022153016
  44. Kim S, Chen J, Cheng T, et al. PubChem 2025 update. Nucleic Acids Res. 2025;53(D1):D1516-D1525. doi: 10.1093/nar/gkae1059
  45. White NJ, Chotivanich K. Artemisinin-resistant malaria. Clin Microbiol Rev. 2024;37(4):e00109-24. doi: 10.1128/cmr.00109-24
  46. Hammond J, Leister-Tebbe H, Gardner A, et al. Oral nirmatrelvir for high-risk, nonhospitalized adults with Covid-19. N Engl J Med. 2022;386(15):1397-1408. doi: 10.1056/NEJMoa2118542
  47. Burley SK, Bhikadiya C, Bi C, et al. RCSB Protein Data Bank: powerful new tools for exploring 3D structures of biological macromolecules for basic and applied research and education in fundamental biology, biomedicine, biotechnology, bioengineering and energy sciences. Nucleic Acids Res. 2021;49(D1):D437-D451. doi: 10.1093/nar/gkaa1038
  48. Eberhardt J, Santos-Martins D, Tillack AF, Forli S. AutoDock Vina 1.2.0: New docking methods, expanded force field, and Python bindings. J Chem Inf Model. 2021;61(8):3891-3898. doi: 10.1021/acs.jcim.1c00203
  49. Lu C, Wu C, Ghoreishi D, et al. OPLS4: Improving Force Field Accuracy on Challenging Regimes of Chemical Space. J Chem Theory Comput. 2021;17(7):4291-4300. doi: 10.1021/acs.jctc.1c00302
  50. Braga C, Travis KP. A configurational temperature Nosé-Hoover thermostat. J Chem Phys. 2005;123(13):134101. doi: 10.1063/1.2013227
  51. Janek J, Kolafa J. Novel barostat implementation for molecular dynamics. J Chem Phys. 2024;160(18):184111. doi: 10.1063/5.0193281
  52. Genheden S, Ryde U. The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities. Expert Opin Drug Discov. 2015;10(5):449-461. doi: 10.1517/17460441.2015.1032936
  53. Majdalawieh AF, Yousef SM, Abu-Yousef IA. Potential immunomodulatory role of sesamin in combating immune dysregulation associated with COVID-19. Asian Pac J Trop Biomed. 2021;11(10):421-428. doi: 10.4103/2221-1691.326096
  54. Zhu Y-W, Yan X-F, Ye T-J, et al. Analyzing the potential therapeutic mechanism of Huashi Baidu Decoction on severe COVID-19 through integrating network pharmacological methods. J Tradit Complement Med. 2021;11(2):180-187. doi: 10.1016/j.jtcme.2021.01.004
  55. Hojo-Souza NS, Pereira DB, Mendes TA, et al. CD4+ T cells apoptosis in Plasmodium vivax infection is mediated by activation of both intrinsic and extrinsic pathways. Malar J. 2015;14:5. doi: 10.1186/1475-2875-14-5
  56. Newton K, Strasser A, Kayagaki N, Dixit VM. Cell death. Cell. 2024;187(2):235-256. doi: 10.1016/j.cell.2023.11.044
  57. Jahani M, Dokaneheifard S, Mansouri K. Hypoxia: A key feature of COVID19 launching activation of HIF-1 and cytokine storm. J Inflamm (Lond). 2020;17:33. doi: 10.1186/s12950-020-00263-3
  58. Qiu B, Yuan P, Du X, Jin H, Du J, Huang Y. Hypoxia inducible factor-1α is an important regulator of macrophage biology. Heliyon. 2023;9(6):e17167. doi: 10.1016/j.heliyon.2023.e17167
  59. Grimes JM, Grimes KV. p38 MAPK inhibition: A promising therapeutic approach for COVID-19. J Mol Cell Cardiol. 2020;144:63-65. doi: 10.1016/j.yjmcc.2020.05.007
  60. Kumar S, Haile MT, Hoopmann MR, et al. Plasmodium falciparum calcium-dependent protein kinase 4 is critical for male gametogenesis and transmission to the mosquito vector. mBio. 2021;12(6):e0257521. doi: 10.1128/mBio.02575-21
  61. Araki C, Takemoto D, Kitagawa Y, et al. Sesamin metabolites suppress the induction of cellular senescence. Nutrients. 2023;15(7):1627. doi: 10.3390/nu15071627
  62. Anabire NG, Aryee PA, Abdul-Karim A, et al. Prevalence of malaria and hepatitis B among pregnant women in Northern Ghana: comparing RDTs with PCR. PLoS One. 2019;14(2):e0210365. doi: 10.1371/journal.pone.0210365
  63. Cheema PS, Nandi D, Nag A. Exploring the therapeutic potential of forkhead box O for outfoxing COVID-19. Open Biol. 2021;11(6):210069. doi: 10.1098/rsob.210069
  64. Martin-Alonso A, Cohen A, Quispe-Ricalde MA, et al. Differentially expressed microRNAs in experimental cerebral malaria and their involvement in endocytosis, adherens junctions, FoxO and TGF-β signalling pathways. Sci Rep. 2018;8(1):11277. doi: 10.1038/s41598-018-29721-y
  65. Fan D, Yang Z, Liu F, et al. Sesamin protects against cardiac remodeling via Sirt3/ROS pathway. Cell Physiol Biochem. 2017;44(6):2212-2227. doi: 10.1159/000486026
  66. Corbett Y, Parapini S, D'Alessandro S, et al. Involvement of Nod2 in the innate immune response elicited by malarial pigment hemozoin. Microbes Infect. 2015;17(3):184-194. doi: 10.1016/j.micinf.2014.11.001
  67. Alvarez-Simon D, Ait Yahia S, de Nadai P, et al. NOD-like receptors in asthma. Front Immunol. 2022;13:928886. doi: 10.3389/fimmu.2022.928886
  68. Wu X, Gowda NM, Kawasawa YI, Gowda DC. A malaria protein factor induces IL-4 production by dendritic cells via PI3K–Akt–NF-κB signaling independent of MyD88/TRIF and promotes Th2 response. J Biol Chem. 2018;293(27):10425-10434. doi: 10.1074/jbc.AC.118.001720
  69. Abu-Eid R, Ward FJ. Targeting the PI3K/Akt/mTOR pathway: A therapeutic strategy in COVID-19 patients. Immunol Lett. 2021;240:1-8. doi: 10.1016/j.imlet.2021.09.005
  70. Fang Q, Zhu Y, Wang Q, Song M, Gao G, Zhou Z. Suppression of cyclooxygenase 2 increases chemosensitivity to sesamin through the Akt‑PI3K signaling pathway in lung cancer cells. Int J Mol Med. 2019;43(1):507-516. doi: 10.3892/ijmm.2018.3939
  71. Kritas SK, Ronconi G, Caraffa AL, Gallenga CE, Ross R, Conti M. Mast cells contribute to coronavirus-induced inflammation: new anti-inflammatory strategy. J Biol Regul Homeost Agents. 2020;34(1):9-14. doi: 10.23812/20-Editorial-Kritas
  72. Kyriazopoulou E, Poulakou G, Milionis H, et al. Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial. Nat Med. 2021;27(10):1752-1760. doi: 10.1038/s41591-021-01499-z
  73. Li ZL, Gao M, Yang MS, Xiao XF, Liu JJ, Yang BC. Sesamin attenuates intestinal injury in sepsis via the HMGB1/TLR4/IL-33 signalling pathway. Pharm Biol. 2020;58(1):898-904. doi: 10.1080/13880209.2020.1787469
  74. Hoffmeister B, Aguilar Valdez AD. Elevated admission C-reactive protein to albumin ratios are associated with disease severity and respiratory complications in adults with imported falciparum malaria. Trans R Soc Trop Med Hyg. 2022;116(5):492-500. doi: 10.1093/trstmh/trab167
  75. Kalabin A, Mani VR, Valdivieso SC, Donaldson B. Does C reactive protein/Albumin ratio have prognostic value in patients with COVID-19. J Infect Dev Ctries. 2021;15(8):1086-1093. doi: 10.3855/jidc.14826
  76. Deng Q, Rasool RU, Russell RM, Natesan R, Asangani IA. Targeting androgen regulation of TMPRSS2 and ACE2 as a therapeutic strategy to combat COVID-19. iScience. 2021;24(3):102254. doi: 10.1016/j.isci.2021.102254
  77. Duncombe CJ, Sen N, Watson FN, et al. Androgens inhibit protective CD8+ T cell responses against pre-erythrocytic malaria parasites in mice. Nat Commun. 2025;16(1):5172. doi: 10.1038/s41467-025-60193-7
  78. Surachetpong W, Singh N, Cheung KW, Luckhart S. MAPK ERK signaling regulates the TGF-β1-dependent mosquito response to Plasmodium falciparum. PLoS Pathog. 2009;5(4):e1000366. doi: 10.1371/journal.ppat.1000366
  79. Zhao H, Gong J, Li L, et al. Vitamin E relieves chronic obstructive pulmonary disease by inhibiting COX2-mediated p-STAT3 nuclear translocation through the EGFR/MAPK signaling pathway. Lab Invest. 2022;102(3):272-280. doi: 10.1038/s41374-021-00652-z
  80. Aliyu M, Zohora FT, Anka AU, et al. Interleukin-6 cytokine: An overview of the immune regulation, immune dysregulation, and therapeutic approach. Int Immunopharmacol. 2022;111:109130. doi: 10.1016/j.intimp.2022.109130
  81. Mendonça VR, Souza LC, Garcia GC, et al. DDX39B (BAT1), TNF and IL6 gene polymorphisms and association with clinical outcomes of patients with Plasmodium vivax malaria. Malar J. 2014;13:278. doi: 10.1186/1475-2875-13-278
  82. Vatansever HS, Becer E. Relationship between IL-6 and COVID-19: to be considered during treatment. Future Virol. 2020;15(12):817-822. doi: 10.2217/fvl-2020-0168
  83. Dawson RE, Jenkins BJ, Saad MI. IL-6 family cytokines in respiratory health and disease. Cytokine. 2021;143:155520. doi: 10.1016/j.cyto.2021.155520
  84. Vagapova ER, Lebedev TD, Prassolov VS. Viral fibrotic scoring and drug screen based on MAPK activity uncovers EGFR as a key regulator of COVID-19 fibrosis. Sci Rep. 2021;11(1):11234. doi: 10.1038/s41598-021-90701-w
  85. Xu Z, Qin F, Yuan L, et al. EGFR DNA methylation correlates with EGFR expression, immune cell infiltration, and overall survival in lung adenocarcinoma. Front Oncol. 2021;11:691915. doi: 10.3389/fonc.2021.691915
  86. Lycett G, Blass C, Louis C. Developmental variation in epidermal growth factor receptor size and localization in the malaria mosquito, Anopheles gambiae. Insect Mol Biol. 2001;10(6):619-628. doi: 10.1046/j.0962-1075.2001.00302.x
  87. Dkhil MA, Al-Shaebi EM, Al-Quraishy S. Effect of Indigofera oblongifolia on the hepatic oxidative status and expression of inflammatory and apoptotic genes during blood-stage murine malaria. Oxid Med Cell Longev. 2019;2019:8264861. doi: 10.1155/2019/8264861
  88. Karabulut Uzuncakmak S, Dirican E, Naldan ME, Kesmez Can F, Halıcı Z. Investigation of CYP2E1 and Caspase-3 Gene Expressions in COVID-19 patients. Gene Rep. 2022;26:101497. doi: 10.1016/j.genrep.2022.101497
  89. Zhou C, Li W, Shao J, Zhao J, Chen C. Analysis of the clinicopathologic characteristics of lung adenocarcinoma with CTNNB1 mutation. Front Genet. 2020;10:1367. doi: 10.3389/fgene.2019.01367
  90. Ghosh N, Saha I, Sharma N. Interactome of human and SARS-CoV-2 proteins to identify human hub proteins associated with comorbidities. Comput Biol Med. 2021;138:104889. doi: 10.1016/j.compbiomed.2021.104889
  91. Zhang YH, Xie LH, Li J, Qi YW, Shi JJ. Classification and clinical significance of immunogenic cell death-related genes in Plasmodium falciparum infection determined by integrated bioinformatics analysis and machine learning. Malar J. 2024;23(1):48. doi: 10.1186/s12936-024-04877-3
  92. Truan JS, Chen JM, Thompson LU. Comparative effects of sesame seed lignan and flaxseed lignan in reducing the growth of human breast tumors (MCF-7) at high levels of circulating estrogen in athymic mice. Nutr Cancer. 2012;64(1):65-71. doi: 10.1080/01635581.2012.630165
  93. Li Y, Chen J, Xi R, et al. Sesamin alleviates androgenetic alopecia by targeting the AR MAPK Wnt axis. Sci Rep. 2026;16(1):2985. doi: 10.1038/s41598-025-32856-4
  94. Wanachewin O, Boonmaleerat K, Pothacharoen P, Reutrakul V, Kongtawelert P. Sesamin stimulates osteoblast differentiation through p38 and ERK1/2 MAPK signaling pathways. BMC Complement Altern Med. 2012;12:71. doi: 10.1186/1472-6882-12-71
  95. Gomes AC, Borges A, Zoca DG, et al. Larvicidal potential of extracts and isolated compounds from Piper cubeba fruits against Aedes aegypti (Diptera: Culicidae) larvae. Nat Prod Res. 2023;37(16):2787-2794. doi: 10.1080/14786419.2022.2131784
  96. Moussavi N, Malterud KE, Mikolo B, et al. Identification of chemical constituents of Zanthoxylum heitzii stem bark and their insecticidal activity against the malaria mosquito Anopheles gambiae. Parasit Vectors. 2015;8:503. doi: 10.1186/s13071-015-1113-x
  97. Wang CY, Yen CC, Hsu MC, Wu YT. Self-nanoemulsifying drug delivery systems for enhancing solubility, permeability, and bioavailability of sesamin. Molecules. 2020;25(14):3119. doi: 10.3390/molecules25143119
  98. Yin H, Zhu L, Wang X, Wang Z, Wang H, Liu Y. Sesamin exhibits potential food–drug interactions through the inhibition of cytochrome P450S and human UDP-glucuronosyltransferases in vitro. RSC Adv. 2026;16(14):12570-12578. doi: 10.1039/d6ra00237d
  99. Rizzuti B. Molecular simulations of proteins: From simplified physical interactions to complex biological phenomena. Biochim Biophys Acta Proteins Proteom. 2022;1870(3):140757. doi: 10.1016/j.bbapap.2022.140757
  100. Wu X, Xu LY, Li EM, Dong G. Application of molecular dynamics simulation in biomedicine. Chem Biol Drug Des. 2022;99(5):789-800. doi: 10.1111/cbdd.14038
  101. Khodadadi S, Pawlus S, Roh JH, Garcia Sakai V, Mamontov E, Sokolov AP. The origin of the dynamic transition in proteins. J Chem Phys. 2008;128(19):195106. doi: 10.1063/1.2927871
  102. Wang E, Sun H, Wang J, et al. End-point binding free energy calculation with MM/PBSA and MM/GBSA: strategies and applications in drug design. Chem Rev. 2019;119(16):9478-9508. doi: 10.1021/acs.chemrev.9b00055
Share
Back to top
Eurasian Journal of Medicine and Oncology, Electronic ISSN: 2587-196X Print ISSN: 2587-2400, Published by AccScience Publishing